Accelerating Discovery of Next Generation Human Medicines
Seattle, WA
- Tweets 541
- Following 59
- Followers 194
- Likes 92
Oct 28 webinar: Curi Bio + Greenstone Biosciences share new BAG3-mutant cardiac disease data from 3D EHTs on Mantarray™: lower contractility, loss of pacing fidelity, and reduced reserve under verapamil.
Register: hubs.ly/Q04yfdYP0
#DilatedCardiomyopathy #iPSC #NAMs
32
Heading to #iMND2026? Meet @Curi_Bio in Rotterdam, Sept. 30-Oct. 2, presenting our latest research on lentiviral optogenetic engineering of human 3D neuromuscular junctions.
Schedule a 1-on-1: hubs.ly/Q04y55Pv0
#NAMs #3DTissueModels #CuriBio
14
Heading to #WMS2026 in Hiroshima? @Curi_Bio is presenting new data on gene therapy capsid screening in human 3D engineered muscle tissues and AI-guided exercise protocols for 3D NMJ tissues.
Connect with our team to learn more: hubs.ly/Q04y9Qz80
#GeneTherapy #CuriBio
21
Today at #iMPSS2026: @Curi_Bio's Nick Geisse on how human functional data from NAMs can help de-risk drug discovery.
📍 Session 8 🕑 14:30–14:50 | Huzhou Hall
See how 3D tissue engineering can help separate real signal from noise.👉 hubs.ly/Q04y551F0
#NAMs #DrugDiscovery
1
2
46
BoNT potency testing is moving beyond the MLB. At #SPS2026, @Curi_Bio will share new data from the 3D NMJ model. See the data presentation and poster, or visit Booth 10 in Montreal, Sept 21–23.
🔗 hubs.ly/Q04xW3630
#BoNT #NAMs #3DTissueModels #iPSC
1
40
Read our recent press release here: hubs.ly/Q04xVZ8Z0
3
🚀 iMPSS 2026 is underway in Nanjing.
At the summit? Catch @Curi_Bio’s talk: “Functional Human Data from NAMs: Encompassing the Spectrum of Drug Discovery” & meet the team to see how our 3D ecosystem can de-risk your pipeline.
👉hubs.ly/Q04xVKW60
#iMPSS2026 #NAMs
18
Are your CNS safety models leaving translational gaps for ASOs, CRISPR, and RNA therapies? Join @Curi_Bio at #SPS2026 for a session on CNS Safety Pharmacology in the NAMs era. Meet us at Booth 10 or Schedule here: hubs.ly/Q04xPMmQ0
#SafetyPharmacology #NAMs #CuriBio
31
Attending #ODC2026 Sept 17–18 at CHA BIO Complex? Don't miss Curi Bio's poster presentation on modeling genetic cardiomyopathies & arrhythmias using 3D EHTs!
👤 Presenter: Nari Kim, M.D., Ph.D.
📌 Topic: 3D EHT Contractility Platforms
📩 Book here! hubs.ly/Q04xBbhg0
19
For #DM1 Awareness Day: @Curi_Bio’s patient-derived iPSC 3D muscle tissues capture repeat-length-dependent force loss, force rescue after CRISPR correction, and abnormal calcium kinetics, functional readouts for drug discovery. Read the blog & app note: hubs.ly/Q04xvQy10
1
1
53
Heading to China for APAC Summit of iMPSS 2026 (Sept 21–24)!
Connect with @Curi_Bio & catch Dr. Geisse's presentation on the future of neuromuscular disease, cardiac safety, and muscle-targeted therapeutics.
🔗 hubs.ly/Q04xsyHF0
#Organoids #DrugDiscovery #Biotech
14
Heading to Montreal 🇨🇦 for #SPS2026? Visit @Curi_Bio at Booth 10 to explore our 3D human tissue models & functional platforms for drug safety! Catch our co-chaired CNS session & BoNT potency testing presentations.
🗓 Sep 21–23 🔗 hubs.ly/Q04xfG3C0
#SafetyPharmacology
16
At EU-METAHEART in Torino, Sept 15–16? 🇮🇹 Meet the @Curi_Bio team for hands-on personalized consultations:
✔️ 3D contractility ✔️ metabolic studies, and ✔️ cardiac models
Schedule here: hubs.ly/Q04xj8-f0
#Cardiomyocytes #Mantarray #3DCellCulture #CuriBio #InVitroModels
16
~90% of drug candidates that succeed in animals fail in human trials. The translational gap is a data problem. @Curi_Bio’s 3D human tissue assays generate functional data for safety, efficacy, and potency testing.
Explore Curi Engine™: hubs.ly/Q04x9fQp0
#DrugDiscovery
18
Heading to EU-METAHEART in Torino? 🇮🇹 Catch the @Curi_Bio team:
🗓️ Sept 14 (15:45): Mantarray Tech Presentation
🗓️ Sept 15–16: Hands-on EHT Workshops
Learn how 3D tissue contractility powers drug discovery!
👉 Schedule a meeting: hubs.ly/Q04x34-50
#EUMETAHEART #Mantarray
12